Trending Stocks: Teladoc, Inc. (NYSE:TDOC), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Alcoa Inc. (NYSE:AA), Celldex Therapeutics, Inc. (NASDAQ:CLDX),

Teladoc, Inc. (NYSE:TDOC) said that, it will be issuing its Q415 quarterly earnings data on Wednesday, March 2nd. Analysts expect the company to announce earnings of ($0.42) per share and revenue of $21.89 million for the quarter.

Teladoc, Inc. (NYSE:TDOC) belongs to Technology sector. Its net profit margin is -73.90% and weekly performance is -8.53%. On last trading day company shares ended up at $13.83. Teladoc, Inc. (NYSE:TDOC) distance from 50-day simple moving average (SMA50) is -15.32%.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) had its price target reduced by RBC Capital from $155.00 to $125.00 in a report issued on Friday morning, AnalystRatings.NETreports. They currently have an outperform rating on the stock.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) shares increased 2.16% in last trading session and ended the day at $81.87. BMRN Gross Margin is 82.60% and its return on assets is -9.20%. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) quarterly performance is -14.77%.

On 23 February, Alcoa Inc. (NYSE:AA) said that, Deere & Co., headquartered in Moline, and Alcoa, with its Alcoa Davenport Works facility in Riverdale, both were selected in the annual ranking on corporate reputation. Deere ranked 46th on the world’s Top 50 Most Admired Companies list. The top five companies on the 2016 Most Admired list were Apple, Alphabet, Amazon, Berkshire Hathaway and Walt Disney.

Alcoa Inc. (NYSE:AA) ended the last trading day at $8.93. Company weekly volatility is calculated as 4.26% and price to cash ratio as 6.12. Alcoa Inc. (NYSE:AA) showed a weekly performance of 0.22%.

On 25 February, Celldex Therapeutics, Inc. (NASDAQ:CLDX) reported business and financial highlights for the fourth quarter and year ended December 31, 2015. Cash, cash equivalents and marketable securities as of December 31, 2015 were $289.9 million compared to $304.6 million as of September 30, 2015.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares moved down -10.76% in last trading session and ended the day at $6.80. CLDX return on assets is -34.40%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) quarterly performance is -61.99%.

Johnson Outdoors Inc. (NASDAQ:JOUT) will hold its annual shareholder meeting on March 2, 2016 beginning at 10:00 a.m. Central Time at the Company’s global headquarters, located at 555 Main Street in Racine, Wisconsin. Doors will open at 9:30 a.m.

Johnson Outdoors Inc. (NASDAQ:JOUT) shares increased 0.55% in last trading session and ended the day at $21.93. JOUT Gross Margin is 39.90% and its return on assets is 4.50%. Johnson Outdoors Inc. (NASDAQ:JOUT) quarterly performance is -8.78%.

Leave a Reply

Your email address will not be published. Required fields are marked *